bca101,pembrolizumab,cetuximab
bicara,merck,eli lilly
['bca101', 'bca101 ', 'cetuximab', 'keytruda', 'bicara']
#asco23 discussant of bca101 trial, dr ezra cohen, says results encouraging in 1st line h&amp;n, with a "signal for efficacy emerging" in hpv neg patients. and here's his slide w data of a previous trial of cetuximab + keytruda (might make any partnering talks harder for bicara?) 
Pharma and biotech reporter, found a home at Evaluate Vantage.